TY - JOUR
T1 - Transitions of disability, disability-free life expectancy and health insurance among adults aged 50 and older in Mexico
T2 - A multistate life table analysis
AU - Cabrero Castro, Jose Eduardo
AU - García-Peña, Carmen
AU - Ramírez Aldana, Ricardo
N1 - Publisher Copyright:
©
PY - 2021/8/5
Y1 - 2021/8/5
N2 - Objectives To analyse the transitions of disability onset and recovery, estimate life expectancy (LE) with and without disability and explore the relation between insurance and disability patterns in the population aged 50+ in Mexico. Design Multistate life table analysis of data from a longitudinal cohort survey. Setting Data came from the Mexican Health and Aging Study, a longitudinal and representative survey of older adults in Mexico. Participants 10 651 individuals aged 50+ interviewed in 2012 and 2015, including those who died between waves. Primary and secondary outcome measures Disability is measured using the activities of daily living (ADL) scale. Transition rates between disability free, ADL disabled and death were employed to estimate total life expectancy (TLE) and disability-free life expectancy (DFLE). Results 46% of the individuals who reported an ADL limitation in 2012 recover from disability by 2015. TLE at age 60 for people without ADL limitations is 30 years (95% CI 28.9 to 31), out of which 4.7 years (95% CI 4.1 to 5.4) are lived with ADL limitations, while TLE at age 60 in the initially disabled is 18.7 years (95% CI 17.3 to 20), with 9.4 years (95% CI 8.4 to 10.3) lived with disability. DFLE at age 60 in people with social security is 24.2 years (95% CI 23.3 to 25.2), in people with public insurance is 24.6 years (95% CI 23.7 to 25.4) and in uninsured people is 26.9 years (95% CI 25.9 to 27.9). Conclusions In Mexico, a substantial proportion of ADL disabled individuals recover from disability. Nevertheless, initially disabled individuals have a considerably lower DFLE regardless of age when compared with initially active individuals. There appeared to be no differences in terms of disability and LEs between the individuals with social security and public insurance.
AB - Objectives To analyse the transitions of disability onset and recovery, estimate life expectancy (LE) with and without disability and explore the relation between insurance and disability patterns in the population aged 50+ in Mexico. Design Multistate life table analysis of data from a longitudinal cohort survey. Setting Data came from the Mexican Health and Aging Study, a longitudinal and representative survey of older adults in Mexico. Participants 10 651 individuals aged 50+ interviewed in 2012 and 2015, including those who died between waves. Primary and secondary outcome measures Disability is measured using the activities of daily living (ADL) scale. Transition rates between disability free, ADL disabled and death were employed to estimate total life expectancy (TLE) and disability-free life expectancy (DFLE). Results 46% of the individuals who reported an ADL limitation in 2012 recover from disability by 2015. TLE at age 60 for people without ADL limitations is 30 years (95% CI 28.9 to 31), out of which 4.7 years (95% CI 4.1 to 5.4) are lived with ADL limitations, while TLE at age 60 in the initially disabled is 18.7 years (95% CI 17.3 to 20), with 9.4 years (95% CI 8.4 to 10.3) lived with disability. DFLE at age 60 in people with social security is 24.2 years (95% CI 23.3 to 25.2), in people with public insurance is 24.6 years (95% CI 23.7 to 25.4) and in uninsured people is 26.9 years (95% CI 25.9 to 27.9). Conclusions In Mexico, a substantial proportion of ADL disabled individuals recover from disability. Nevertheless, initially disabled individuals have a considerably lower DFLE regardless of age when compared with initially active individuals. There appeared to be no differences in terms of disability and LEs between the individuals with social security and public insurance.
KW - epidemiology
KW - organisation of health services
KW - public health
UR - http://www.scopus.com/inward/record.url?scp=85112330419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112330419&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2020-045261
DO - 10.1136/bmjopen-2020-045261
M3 - Article
C2 - 34353793
AN - SCOPUS:85112330419
SN - 2044-6055
VL - 11
JO - BMJ open
JF - BMJ open
IS - 8
M1 - 045261
ER -